Bayer Grants4Apps Shanghai 2018 Launches Third Cohort with Dual-Track Innovation Program

February 22, 2016, and July 3, 2017, were two significant dates when Bayer, a Fortune Global 500 company, launched the first and second phases of its “Bayer Grants4Apps Shanghai Startup Program” in China, achieving remarkable results.In 2018, Bayer’s Grants4Apps program, which has garnered widespread attention across the industry, launched its third edition! Continuing with its dual-track approach comprising the “Incubator Program” and the “Dealmaker Program,” the initiative seeks out the most promising innovative projects in China and supports their growth. As a key supporting partner, VCBeat will provide you with the latest updates on Bayer China’s 2018 Grants4Apps program.

(Scan the QR code in the image to apply for the project)

Grants4Apps Project Application Website:http://www.grants4apps.com/shanghai

For more information about the project, please visit:http://www.grants4apps.bayer.com

The Grants4Apps project, an open innovation initiative focused on the healthcare sector, originated in Berlin, Germany. It began its global rollout in 2016. As a key destination for this global expansion, Bayer China launched the “Bayer Start-up Program Shanghai” under the Grants4Apps umbrella in Shanghai.

This year's event isGrants4Apps “Bayer G4A Shanghai” Phase III still consists of the “Incubator Program” and the “Dealmaker Program.”

Unlike in previous years:The “Incubator Program” officially opened for applications on April 9, 2018, with the submission deadline set for May 31, 2018. The “Dealmaker Program,” by contrast, will run throughout 2018, during which Bayer will periodically issue business challenges to Chinese innovative enterprises via the official Grants4Apps website. We encourage you to stay tuned and participate actively.

Bayer has been supporting the development of innovative enterprises in China by providing them with assistance through the Bayer Grants4Apps program. In partnership with Bayer, innovative companies canThe “Incubator Program” demonstrates its innovation capabilities, reflecting the value that companies create for doctors, patients, and consumers in China. We are confident that both Chinese innovative enterprises and Bayer China’s Grants4Apps program will achieve greater growth through collaborative innovation.

This year, Bayer will continue to provide the following to the selected startups:Support in Four Areas:

88 Days in Bayer

Startup Team (3–5 individuals) will be invited to Citigroup Tower in Lujiazui Financial Center, Shanghai, China, to undergo an 88-day program of training and mentoring (July 9, 2018–October 4, 2018). The training content will include, but not be limited to, business model development, market analysis, and investment strategy formulation.

Bayer will provide customized courses based on the actual needs of the selected participants. A mentorship team composed of senior executives from Bayer China will offer professional guidance to the selected teams, comprehensively assisting startups in resolving various challenging issues encountered or anticipated during their development.

1 Demo day

DurationFollowing the 88-day project training and mentoring program, each entrepreneurial team will present their products and business development achievements to the public on Demo Day. Bayer partner companies, investors, fellow entrepreneurs, major media outlets, and Bayer employees will be present to learn about the startup projects, thereby enhancing the industry visibility of these initiatives.

360° Interpersonal Relationship Achievement

InDuring the “Incubator Program,” innovative project teams can engage in close exchanges with Bayer China personnel, investors, healthcare experts, and other entrepreneurs to build their professional networks, integrate industry resources, and promote project development.

In previous incubation programs, selected participants“Huashengmi” leveraged the network connections accumulated during the “Incubator Program” to secure a spot in the Dubai 100 training camp and obtain financing. In addition to securing funding and partnering with DXY, “Ruijia” gained numerous partners through this “Incubator Program,” embarking on a new chapter of growth.

RMB 30,000 in financial support

Each selected company will receiveA financial support of RMB 30,000, which the selected enterprises may allocate at their discretion.

The Dealmaker Program is a challenge-based initiative through which Bayer engages innovative companies that align with its business challenges—specifically, startups that have completed Series A or B financing rounds, or are more mature. This year, Bayer will continue to issue business challenges to Chinese innovators on an irregular basis via the Grants4Apps official website (i.e., the application portal), focusing on critical pain points and difficulties in the healthcare industry. Bayer encourages all eligible innovative enterprises to actively participate.

April 24, 2018, 14:00–17:30，VCBeatSiXiangHui Salonwill beShanghaiHiMed MedTech Innovation SpaceJoin us, together with Bayer, Pharmacy Online Mall, and Yunkai Yamei, to explore innovative pathways for pharmaceutical companies and new models of collaboration between innovative enterprises and pharma firms. We look forward to your participation!

For details and registration, please proceed to：http://www.huodongxing.com/event/4434935998000